Terra Alpha Investments LLC purchased a new stake in shares of Agilent Technologies, Inc. (NYSE:A - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 23,895 shares of the medical research company's stock, valued at approximately $3,210,000. Agilent Technologies makes up about 3.2% of Terra Alpha Investments LLC's investment portfolio, making the stock its 13th biggest position.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Madison Investment Advisors LLC bought a new position in shares of Agilent Technologies during the fourth quarter worth about $94,051,000. Massachusetts Financial Services Co. MA raised its holdings in Agilent Technologies by 3.5% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 15,589,874 shares of the medical research company's stock worth $2,314,784,000 after purchasing an additional 525,214 shares during the last quarter. FMR LLC lifted its position in shares of Agilent Technologies by 62.2% in the 3rd quarter. FMR LLC now owns 1,287,665 shares of the medical research company's stock worth $191,193,000 after purchasing an additional 493,947 shares during the period. Raymond James Financial Inc. acquired a new position in Agilent Technologies in the fourth quarter valued at $48,172,000. Finally, Worldquant Millennium Advisors LLC bought a new stake in shares of Agilent Technologies during the 3rd quarter valued at about $49,449,000.
Agilent Technologies Price Performance
A stock traded up $0.44 during mid-day trading on Friday, reaching $120.72. 3,041,425 shares of the company traded hands, compared to its average volume of 1,682,254. The company has a fifty day moving average price of $137.07 and a 200-day moving average price of $137.45. Agilent Technologies, Inc. has a 52-week low of $117.17 and a 52-week high of $155.35. The company has a market capitalization of $34.42 billion, a P/E ratio of 27.75, a P/E/G ratio of 3.43 and a beta of 1.11. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66.
Agilent Technologies (NYSE:A - Get Free Report) last posted its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.04. The business had revenue of $1.68 billion for the quarter, compared to analysts' expectations of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. As a group, analysts anticipate that Agilent Technologies, Inc. will post 5.57 earnings per share for the current year.
Agilent Technologies Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be given a dividend of $0.248 per share. The ex-dividend date is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.82%. Agilent Technologies's dividend payout ratio (DPR) is presently 22.76%.
Analysts Set New Price Targets
Several equities research analysts have weighed in on A shares. Barclays raised shares of Agilent Technologies from an "underweight" rating to an "equal weight" rating and lifted their price target for the company from $135.00 to $145.00 in a research note on Monday, February 10th. Citigroup boosted their target price on shares of Agilent Technologies to $165.00 and gave the stock a "buy" rating in a research report on Thursday, December 19th. Sanford C. Bernstein dropped their price target on shares of Agilent Technologies from $140.00 to $135.00 and set a "market perform" rating on the stock in a research report on Tuesday, November 26th. Bank of America lowered their price objective on Agilent Technologies from $153.00 to $150.00 and set a "neutral" rating for the company in a research note on Friday, December 13th. Finally, StockNews.com raised Agilent Technologies from a "hold" rating to a "buy" rating in a research report on Tuesday, December 24th. Seven investment analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. According to MarketBeat.com, Agilent Technologies currently has an average rating of "Moderate Buy" and an average price target of $146.15.
Get Our Latest Analysis on Agilent Technologies
Insider Buying and Selling
In other Agilent Technologies news, VP Rodney Gonsalves sold 1,908 shares of the company's stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the completion of the transaction, the vice president now owns 21,786 shares of the company's stock, valued at $2,657,456.28. This represents a 8.05 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the sale, the chief executive officer now directly owns 39,652 shares in the company, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The disclosure for this sale can be found here.
About Agilent Technologies
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Featured Articles
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
